ArticleMolecular pharmacology2019

Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.

M Michael Dcona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.